FasL:Fas ratio - A prognostic factor in breast carcinomas

Cancer Research

Volumn 60, Issue 4, 2000, Pages 822-828

  Reimer, Toralf ^a   Herrnring, Christina ^a   Koczan, Dirk ^a   Richter, Dagmar ^a   Gerber, Bernd ^a   Kabelitz, Dieter ^b   Friese, Klaus ^a   Thiesen, Hans Jürgen ^a,c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c Institute of Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FIBROADENOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD95; BREAST NEOPLASMS; FAS LIGAND PROTEIN; FEMALE; FIBROADENOMA; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034652611     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Garfinkel, L., Boring, C. C., and Heath, C. W., Jr. Changing trends. An overview of breast cancer incidence and mortality. Cancer (Phila.), 74: 222-227, 1994.
2. Grekou, A. N., Toliou, T., Stravoravdi, P., Patakioufa, F., Tsoukalas, T., Pinakidis, M., and Keramidas, G. Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas. Anticancer Res., 16: 3991-3995, 1996.
3. Marrogi, A. J., Munshi, A., Merogi, A. J., Ohadike, Y., El-Habashi, A., Marrogi, O. L., and Freeman, S. M. Study of tumor infiltrating lymphocytes and transforming growth factor-β as prognostic factors in breast carcinoma. Int. J. Cancer, 74: 492-501, 1997.
4. Browning, M. J., and Bodmer, W. F. MHC antigens and cancer: implications for T-cell surveillance. Curr. Opin. Immunol., 4: 613-618, 1992.
5. Daniel, P. T., Kroidl, A., Cayeux, S., Bargou, R., Blankenstein, T., and Dörken, B. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J. Immunol., 159: 3808-3815, 1997.
6. Miescher, S., Whiteside, T. L., Carrel, S., and von Fliedner, V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136: 1899-1907, 1986.
7. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
8. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krammer, P. H., and Möller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Investig., 69: 415-429, 1993.
9. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. The Fas counter-attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082, 1996.
10. Bennett, M. W., O'Connell, J., O'Sullivan, G. C., Brady, C., Roche, D., Collins, J. K., and Shanahan, F. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J. Immunol., 160: 5669-5675, 1998.
11. Lee, S. H., Kim, S. Y., Lee, J. Y., Shin, M. S., Dong, S. M., Na, E. Y., Park, W. S., Kim, K. M., Kim, C. S., Kim, S. H., and Yoo, N. J. Detection of soluble Fas mRNA using in situ reverse transcription-polymerase chain reaction. Lab. Investig., 78: 453-459, 1998.
12. Vollmers, H. P., Dämmrich, J., Hensel, F., Ribbert, H., Meyer-Bahlburg, A., Ufken-Gaul, T., von Korff, M., and Müller-Hermelink, H. K. Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer (Phila.), 79: 433-440, 1997.
13. Niehans, G. A., Brunner, T., Frizelle, S. P., Liston, J. C., Salerno, C. T., Knapp, D. J., Green, D. R., and Kratzke, R. A. Human lung carcinomas express Fas ligand. Cancer Res., 57: 1007-1012, 1997.
14. Rabinowich, H., Reichert, T. E., Kashii, Y., Gastman, B. R., Bell, M. C., and Whiteside, T. L. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J. Clin. Investig., 101: 2579-2588, 1998.
15. Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., and Galle, P. R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cell-a mechanism of immune evasion? Nat. Med., 2: 1361-1366, 1996.
16. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11: 359-377, 1957.
17. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
18. Holland, P. M., Abramson, R. D., Watson, R., and Gelfand, D. H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA, 88: 7276-7280, 1991.
19. Gibson, U. E. M., Heid, C. A., and Williams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
20. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., and Krammer, P. H. Autocrine T-cell suicide mediated by APO-1. Nature (Lond.), 373: 438-441, 1995.
21. Hill, L. L., Ouhtit, A., Loughlin, S. M., Kripke, M. L., Ananthaswamy, H. N., and Owen-Schaub, L. B. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science (Washington DC), 285: 898-900, 1999.
22. Walczak, H., Dhein, J., Peter, M. E., and Krammer, P. H. Activation-induced T cell death. Cell Death Differ., 3: 245, 1996.
23. Keane, M. M., Ettenberg, S. A., Lowrey, G. A., Russell, E. K., and Lipkowitz, S. Fas expression and function in normal and malignant breast cell lines. Cancer Res., 56: 4791-4798, 1996.
24. Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., and Dörken, B. Overexpression of the death-promoting gene bax-α, which is downregulated in breast cancer, restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Investig., 97: 2651-2659, 1996.
25. Gutierrez, L. S., Eliza, M., Niven-Fairchild, T., Naftolin, F., and Mor, G. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas. Breast Cancer Res, Treat., 54: 245-253, 1999.